Synopsis of recent research by authors named "Wendi Hu"
- Wendi Hu's research primarily focuses on advancements in treatment methodologies for hepatocellular carcinoma (HCC), examining novel therapeutic combinations, minimally invasive surgical techniques, and the biochemical mechanisms that contribute to cancer progression.
- Recent studies co-authored by Hu include investigations into the efficacy of combining envafolimab and lenvatinib with transcatheter arterial chemoembolization for unresectable HCC, as well as comparisons of robotic and laparoscopic liver resection approaches, highlighting potential benefits of robotic methods.
- Additional work by Hu explores the genetic and molecular underpinnings of HCC, such as the role of C8orf76 in regulating ferroptosis and the involvement of fatty acid metabolism pathways in HCC progression, providing insights that could lead to new therapeutic targets.
